Skin TLR7 Triggering Promotes Accumulation of Respiratory Dendritic Cells and Natural Killer Cells

The TLR7 agonist imiquimod has been used successfully as adjuvant for skin treatment of virus-associated warts and basal cell carcinoma. The effects of skin TLR7 triggering on respiratory leukocyte populations are unknown. In a placebo-controlled experimental animal study we have used multicolour fl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackstein, Holger, Hagel, Nicole, Knoche, Angela, Kranz, Sabine, Lohmeyer, Jürgen, von Wulffen, Werner, Kershaw, Olivia, Gruber, Achim D., Bein, Gregor, Baal, Nelli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425551/
https://www.ncbi.nlm.nih.gov/pubmed/22927956
http://dx.doi.org/10.1371/journal.pone.0043320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425551/
https://www.ncbi.nlm.nih.gov/pubmed/22927956
http://dx.doi.org/10.1371/journal.pone.0043320

Ejemplares similares